Primary Cells Market to Reach $2.46 Billion by 2029 | Key Drivers and Future Outlook
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Primary Cells Market?
In recent years, the market size for primary cells has expanded rapidly. It is projected to increase from $1.49 billion in 2024 to $1.67 billion in 2025, growing at a compound annual growth rate (CAGR) of 12.0%. Factors contributing to this growth during the historic period include the escalating occurrence of cancer, rising investment in regenerative medicine research, a surge in demand for monoclonal antibodies, benefits of primary human cells over cell lines, and a progressively increasing prevalence of chronic diseases.
What Growth Rate Is Forecasted for the Primary Cells Market by 2029?
The market size of primary cells is set for a fast-paced growth in the coming years, ballooning up to $2.46 billion by the year 2029, with an impressive compound annual growth rate (CAGR) of 10.1%. Factors contributing to this surge in the forecast period include a rising need for personalized healthcare, an escalating focus on stem cell research, growing investments, and the widespread acceptance of cell-based assays. Key trends during this forecast period are the increasing demand for human primary cells, improvements in research tools and technologies, and the implementation of cell-based therapies.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14165&type=smp
Which Key Companies Are Shaping the Future of the Primary Cells Market?
Major companies operating in the primary cells market are Thermo Fisher Scientific Inc, Merck KGaA, BD Biosciences, Corning Incorporated, Cytiva, Lonza Group Ltd, Charles River Laboratories Inc., STEMCELL Technologies Inc, American Type Culture Collection, Cell Signaling Technology, BioIVT, InvivoGen, HemaCare Corporation, Creative Bioarray Inc., PromoCell GmbH, CellGenix, AllCells LLC, Axol Bioscience Ltd, PBS Biotech Inc, AnaBios Corporation, ReachBio Research Labs, PELOBIOTECH GmbH, Cell Biologics Inc., ZenBio Inc., StemBioSys Inc
Which Factors Are Driving Demand in the Primary Cells Industry?
The anticipated increase in government funding for cancer studies is predicted to boost the primary cells market’s expansion. This funding implies the monetary aid given to a project, organization, initiative or individual, facilitating its progress, operation, or fulfillment of certain objectives. In the primary cells sector, government funding is utilized for research projects, personnel support, equipment and infrastructure, training and education, adherence to regulations, and technology advancement. To illustrate, the American Institute for Cancer Research (AICR), a prominent cancer research organization in the US, requested funding amounting to $49 billion in May 2022 for 2023 – a rise of $4.1 billion from the preceding year’s $46.4 billion. Consequently, the anticipated increase in government funding for cancer research should bolster the primary cell market’s expansion.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=14165&type=smp
How Is the Primary Cells Market Segmented by Several Divisions?
The primary cells market covered in this report is segmented –
1) By Type: Hematopoietic Cells, Dermatophytes, Gastrointestinal Cells, Hepatocytes, Lung Cells, Renal Cells, Heart Cells, Musculoskeletal Cells, Other Primary Cells
2) By Origin: Human Primary Cells, Animal Primary Cells
3) By End User: Pharmaceuticals, Biotechnology Companies, Contract Research Organizations (CRO), Academic And Research Institutes, Other End Users
Subsegments:
1) By Hematopoietic Cells: Bone Marrow-Derived Cells, Peripheral Blood-Derived Cells
2) By Dermatophytes: Keratinocytes, Fibroblasts
3) By Gastrointestinal Cells: Enterocytes, Goblet Cells, Paneth Cells
4) By Hepatocytes: Liver Parenchymal Cells, Hepatic Stellate Cells
5) By Lung Cells: Alveolar Epithelial Cells, Bronchial Epithelial Cells
6) By Renal Cells: Proximal Tubular Cells, Glomerular Cells
7) By Heart Cells: Cardiomyocytes, Cardiac Fibroblasts
8) By Musculoskeletal Cells: Myoblasts, Chondrocytes
9) By Other Primary Cells: Endothelial Cells, Adipocytes
What are the Emerging Market Trends Driving the Growth of the Primary Cells Industry?
Leading businesses in the primary cell market are prioritizing the improvement of cell products, such as cell culture and stem cell products, to bolster research applications and therapeutic developments. A ground-breaking serum-free medium, typically used in cell culture or tissue culture without the presence of serum like fetal bovine serum (FBS) or other animal-derived sera, is being focused on. For instance, in July 2024, advanced stem cell products were launched in India by Bioserve Biotechnologies (India) Private Ltd., a firm specializing in biotechnology and life science solutions. These new offerings from REPROCELL are designed to encourage innovation in scientific research and drug creation, fostering progress in regenerative medicine and therapeutic discovery within the Indian region.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/primary-cells-global-market-report
Which Regions Are Driving Growth in the Primary Cells Market?
North America was the largest region in the primary cells market in 2024. The regions covered in the primary cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14165
This Report Delivers Insight On:
1. How big is the primary cells market, and how is it changing globally?
2. Who are the major companies in the primary cells market, and how are they performing?
3. What are the key opportunities and risks in the primary cells market right now?
4. Which products or customer segments are growing the most in the primary cells market?
5. What factors are helping or slowing down the growth of the primary cells market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
